Which bacteria that cause urinary tract infection are not covered by Bactrim (trimethoprim‑sulfamethoxazole)?

Bacteria Causing UTI Not Covered by Bactrim

Enterococcus species are the most clinically important bacteria causing UTI that Bactrim (trimethoprim-sulfamethoxazole) does NOT reliably cover, despite appearing susceptible on standard laboratory testing. 1, 2, 3

Critical Coverage Gaps

Enterococcus Species (Most Important)

• Enterococcus faecalis and E. faecium appear susceptible in vitro but fail clinically because they can incorporate exogenous folates from urine, completely reversing Bactrim's mechanism of action 2, 3
• Standard susceptibility testing uses folate-free media, creating a dangerous false impression of susceptibility
• When tested in media containing fresh urine, the MIC increases 360-fold 2
• Case reports document bacteremia developing in patients treated with Bactrim for enterococcal UTI, despite in vitro susceptibility 3
• The European Committee on Antimicrobial Susceptibility Testing now categorizes wild-type enterococci as intermediate to trimethoprim/sulfamethoxazole, acknowledging this clinical failure 2

Pseudomonas aeruginosa

• Intrinsically resistant to Bactrim 4
• Not covered by the FDA-approved spectrum 1

Serratia marcescens

• Intrinsically resistant to Bactrim 4
• Not covered by the FDA-approved spectrum 1

Organisms with Increasing Resistance

Escherichia coli (Acquired Resistance)

While E. coli is listed as a covered organism 1, resistance rates are climbing:

• 39.9% resistance to fluoroquinolones and 46.6% resistance to trimethoprim/sulfamethoxazole in recurrent UTI populations 5
• 25.1% resistance rate in ED patients with E. coli UTI 6
• Risk factors for TMP-SMX resistant E. coli include:
  • Recurrent UTI (OR 2.27)
  • Genitourinary abnormalities (OR 2.31)
  • TMP-SMX use within 90 days (OR 8.77) 6

Carbapenem-Resistant Enterobacteriaceae (CRE)

• Only 29% of CRE isolates are susceptible to TMP-SMX 7
• Resistance can develop during treatment, further limiting utility 7

FDA-Approved Coverage (What IS Covered)

According to the drug label, Bactrim covers 1:

• Escherichia coli
• Klebsiella species
• Enterobacter species
• Morganella morganii
• Proteus mirabilis
• Proteus vulgaris

Clinical Pitfalls to Avoid

1. Never rely on standard lab susceptibility reports for Enterococcus - these are misleading and potentially dangerous 3
2. Avoid Bactrim if TMP-SMX resistance exceeds 20% locally per IDSA guidelines 6
3. Do not use Bactrim for complicated UTIs where Pseudomonas or Serratia are likely 4
4. Avoid in patients with recent TMP-SMX exposure (within 90 days) due to high resistance risk 6

Alternative Agents for Non-Covered Organisms

• Enterococcus: Ampicillin remains the drug of choice; alternatives include vancomycin plus aminoglycoside 3, 8
• Pseudomonas/Serratia: Fluoroquinolones, cephalosporins (cefepime), or piperacillin-tazobactam 9
• Resistant E. coli: Fosfomycin (95.5% susceptibility), nitrofurantoin (85.5%), or cefuroxime (82.3%) 5